Device Firms’ ‘Vaginal Rejuvenation’ Marketing Claims Spark US FDA Response

US FDA sent letters to seven laser and ablation product manufacturers that have been marketing their products’ ability to provide "vaginal rejuvenation," or treat sexual dysfunction – claims that Commissioner Scott Gottlieb said have not been cleared or approved.

More from Regulation

More from Policy & Regulation